Related Experiment Video
Updated: Sep 6, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
SM22α cell-specific HIF stabilization mitigates hyperoxia-induced neonatal lung injury
Reiji Ito1, Elizabeth A Barnes1, Xibing Che1
1Department of Pediatrics, Center for Excellence in Pulmonary Biology, Stanford University School of Medicine, Stanford, California.
Insights
Stabilizing hypoxia-inducible factors (HIFs) in specific lung cells protects against hyperoxia-induced injury in neonatal mice. This targeted approach improves lung structure and microvessel density, offering a potential strategy for preventing bronchopulmonary dysplasia.
Area of Science:
- Neonatal Physiology
- Pulmonary Medicine
- Molecular Biology
Background:
- Bronchopulmonary dysplasia (BPD) remains a significant challenge in preterm infant care, despite improved survival rates.
- The underlying mechanisms of BPD, particularly the role of cell-specific hypoxia-inducible factors (HIFs) in neonatal lung injury, are not fully understood.
- Histological hallmarks of BPD include alveolar simplification and reduced lung microvasculature.
Purpose of the Study:
- To investigate the protective effects of HIF stabilization specifically in SM22α-expressing cells against hyperoxia-induced neonatal lung injury.
- To determine the impact of cell-specific HIF-1α stabilization on lung development, microvascular integrity, and associated molecular pathways.
Main Methods:
- Generation of SM22α-specific HIF-1α-stabilized mice (SM22α-PHD1/2-/-) by genetic cross-breeding.
- Exposure of neonatal mice to normoxia (21% O2) or hyperoxia (80% O2) for 14 days, followed by a 10-week recovery period.
- Assessment of lung injury, microvessel density, cell proliferation, gene expression (Angiopoietin-2), and vascular structure in pulmonary artery endothelial cells (PAECs) and pulmonary artery smooth muscle cells (PASMCs).
Main Results:
- SM22α-specific HIF-1α stabilization significantly mitigated hyperoxia-induced lung injury and preserved microvessel density in both neonates and adults.
- Mice with stabilized HIF-1α in SM22α-expressing cells exhibited increased PAEC proliferation and collagen IV expression in pulmonary arteries.
- Enhanced Angiopoietin-2 (Ang2) mRNA expression was observed in PASMCs, and co-culture experiments demonstrated improved tube formation in pulmonary endothelial cells, further augmented by recombinant Ang2.
Conclusions:
- Cell-specific deletion of PHD1 and PHD2 selectively stabilizes HIF-1α in SM22α-expressing cells, offering protection against neonatal lung injury induced by prolonged hyperoxia.
- HIF stabilization in these specific cells preserves endothelial cell proliferation, microvascular density, and lung structure.
- Targeted HIF-1α stabilization presents a promising therapeutic strategy for preventing or mitigating neonatal lung injury and BPD.
Abstract:
Though survival rates for preterm infants are improving, the incidence of chronic lung disease of infancy, or bronchopulmonary dysplasia (BPD), remains high. Histologically, BPD is characterized by larger and fewer alveoli. Hypoxia-inducible factors (HIFs) may be protective in the context of hyperoxia-induced lung injury, but the cell-specific effects of HIF expression in neonatal lung injury remain unknown. Thus, we sought to determine whether HIF stabilization in SM22α-expressing cells can limit hyperoxia-induced neonatal lung injury. We generated SM22α-specific HIF-1α-stabilized mice (SM22α-PHD1/2-/- mice) by cross-breeding SM22α-promotor-driven Cre recombinase mice with prolyl hydroxylase PHD1flox/flox and PHD2flox/flox mice. Neonatal mice were randomized to 21% O2 (normoxia) or 80% O2 (hyperoxia) exposure for 14 days. For the hyperoxia recovery studies, neonatal mice were recovered from normoxia for an additional 10 wk. SM22α-specific HIF-1α stabilization mitigated hyperoxia-induced lung injury and preserved microvessel density compared with control mice for both neonates and adults. In SM22α-PHD1/2-/- mice, pulmonary artery endothelial cells (PAECs) were more proliferative and pulmonary arteries expressed more collagen IV compared with control mice, even under hyperoxic conditions. Angiopoietin-2 (Ang2) mRNA expression in pulmonary artery smooth muscle cells (PASMC) was greater in SM22α-PHD1/2-/- compared with control mice in both normoxia and hyperoxia. Pulmonary endothelial cells (PECs) cocultured with PASMC isolated from SM22α-PHD1/2-/- mice formed more tubes and branches with greater tube length compared with PEC cocultured with PASMC isolated from SM22α-PHD1/2+/+ mice. Addition of Ang2 recombinant protein further augmented tube formation for both PHD1/2+/+ and PHD1/2-/- PASMC. Cell-specific deletion of PHD1 and 2 selectively increases HIF-1α expression in SM22α-expressing cells and protects neonatal lung development despite prolonged hyperoxia exposure. HIF stabilization in SM22α-expressing cells preserved endothelial cell proliferation, microvascular density, increased angiopoietin-2 expression, and lung structure, suggesting a role for cell-specific HIF-1α stabilization to prevent neonatal lung injury.
Related Concept Videos
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Regulation of Angiogenesis and Blood Supply

